Global and United States Oncology/Cancer Drugs Market Insights, Forecast to 2027

Global and United States Oncology/Cancer Drugs Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Oncology/Cancer Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Oncology/Cancer Drugs Market Size Growth Rate by Type
1.2.2 Antimetabolite
1.2.3 Alkaloid drugs
1.2.4 Hormone
1.2.5 Targeted drug
1.2.6 Platinum-based drugs
1.2.7 Other
1.3 Market by Application
1.3.1 Global Oncology/Cancer Drugs Market Size Growth Rate by Application
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Respiratory/Lung Cancer
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Oncology/Cancer Drugs Market Size, Estimates and Forecasts
2.1.1 Global Oncology/Cancer Drugs Revenue 2016-2027
2.1.2 Global Oncology/Cancer Drugs Sales 2016-2027
2.2 Global Oncology/Cancer Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Oncology/Cancer Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Oncology/Cancer Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Oncology/Cancer Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Oncology/Cancer Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Oncology/Cancer Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Oncology/Cancer Drugs Revenue Forecast by Region (2022-2027)
3 Global Oncology/Cancer Drugs Competitor Landscape by Players
3.1 Global Top Oncology/Cancer Drugs Manufacturers by Sales
3.1.1 Global Oncology/Cancer Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Oncology/Cancer Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Oncology/Cancer Drugs Manufacturers by Revenue
3.2.1 Key Oncology/Cancer Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Oncology/Cancer Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Oncology/Cancer Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Oncology/Cancer Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Oncology/Cancer Drugs Revenue in 2020
3.2.6 Global Oncology/Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Oncology/Cancer Drugs Price by Manufacturers
3.4 Global Oncology/Cancer Drugs Manufacturing Base Distribution, Product Types
3.4.1 Oncology/Cancer Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Oncology/Cancer Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Oncology/Cancer Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Oncology/Cancer Drugs Market Size by Type (2016-2021)
4.1.1 Global Oncology/Cancer Drugs Sales by Type (2016-2021)
4.1.2 Global Oncology/Cancer Drugs Revenue by Type (2016-2021)
4.1.3 Oncology/Cancer Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Oncology/Cancer Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global Oncology/Cancer Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Oncology/Cancer Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Oncology/Cancer Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Oncology/Cancer Drugs Market Size by Application (2016-2021)
5.1.1 Global Oncology/Cancer Drugs Sales by Application (2016-2021)
5.1.2 Global Oncology/Cancer Drugs Revenue by Application (2016-2021)
5.1.3 Oncology/Cancer Drugs Price by Application (2016-2021)
5.2 Oncology/Cancer Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global Oncology/Cancer Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Oncology/Cancer Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Oncology/Cancer Drugs Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Oncology/Cancer Drugs Market Size YoY Growth 2016-2027
6.1.1 United States Oncology/Cancer Drugs Sales YoY Growth 2016-2027
6.1.2 United States Oncology/Cancer Drugs Revenue YoY Growth 2016-2027
6.1.3 United States Oncology/Cancer Drugs Market Share in Global Market 2016-2027
6.2 United States Oncology/Cancer Drugs Market Size by Players (International and Local Players)
6.2.1 United States Top Oncology/Cancer Drugs Players by Sales (2016-2021)
6.2.2 United States Top Oncology/Cancer Drugs Players by Revenue (2016-2021)
6.3 United States Oncology/Cancer Drugs Historic Market Review by Type (2016-2021)
6.3.1 United States Oncology/Cancer Drugs Sales Market Share by Type (2016-2021)
6.3.2 United States Oncology/Cancer Drugs Revenue Market Share by Type (2016-2021)
6.3.3 United States Oncology/Cancer Drugs Price by Type (2016-2021)
6.4 United States Oncology/Cancer Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Oncology/Cancer Drugs Sales Forecast by Type (2022-2027)
6.4.2 United States Oncology/Cancer Drugs Revenue Forecast by Type (2022-2027)
6.4.3 United States Oncology/Cancer Drugs Price Forecast by Type (2022-2027)
6.5 United States Oncology/Cancer Drugs Historic Market Review by Application (2016-2021)
6.5.1 United States Oncology/Cancer Drugs Sales Market Share by Application (2016-2021)
6.5.2 United States Oncology/Cancer Drugs Revenue Market Share by Application (2016-2021)
6.5.3 United States Oncology/Cancer Drugs Price by Application (2016-2021)
6.6 United States Oncology/Cancer Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Oncology/Cancer Drugs Sales Forecast by Application (2022-2027)
6.6.2 United States Oncology/Cancer Drugs Revenue Forecast by Application (2022-2027)
6.6.3 United States Oncology/Cancer Drugs Price Forecast by Application (2022-2027)
7 North America
7.1 North America Oncology/Cancer Drugs Market Size YoY Growth 2016-2027
7.2 North America Oncology/Cancer Drugs Market Facts & Figures by Country
7.2.1 North America Oncology/Cancer Drugs Sales by Country (2016-2021)
7.2.2 North America Oncology/Cancer Drugs Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Oncology/Cancer Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Oncology/Cancer Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Oncology/Cancer Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Oncology/Cancer Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Oncology/Cancer Drugs Market Size YoY Growth 2016-2027
9.2 Europe Oncology/Cancer Drugs Market Facts & Figures by Country
9.2.1 Europe Oncology/Cancer Drugs Sales by Country (2016-2021)
9.2.2 Europe Oncology/Cancer Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Oncology/Cancer Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Oncology/Cancer Drugs Market Facts & Figures by Country
10.2.1 Latin America Oncology/Cancer Drugs Sales by Country (2016-2021)
10.2.2 Latin America Oncology/Cancer Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Oncology/Cancer Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Oncology/Cancer Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Oncology/Cancer Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Oncology/Cancer Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Roche
12.1.1 Roche Corporation Information
12.1.2 Roche Description and Business Overview
12.1.3 Roche Oncology/Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Roche Oncology/Cancer Drugs Products Offered
12.1.5 Roche Recent Development
12.2 HENGRUI
12.2.1 HENGRUI Corporation Information
12.2.2 HENGRUI Description and Business Overview
12.2.3 HENGRUI Oncology/Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 HENGRUI Oncology/Cancer Drugs Products Offered
12.2.5 HENGRUI Recent Development
12.3 AstraZeneca
12.3.1 AstraZeneca Corporation Information
12.3.2 AstraZeneca Description and Business Overview
12.3.3 AstraZeneca Oncology/Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 AstraZeneca Oncology/Cancer Drugs Products Offered
12.3.5 AstraZeneca Recent Development
12.4 QILU
12.4.1 QILU Corporation Information
12.4.2 QILU Description and Business Overview
12.4.3 QILU Oncology/Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 QILU Oncology/Cancer Drugs Products Offered
12.4.5 QILU Recent Development
12.5 Sanofi
12.5.1 Sanofi Corporation Information
12.5.2 Sanofi Description and Business Overview
12.5.3 Sanofi Oncology/Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Sanofi Oncology/Cancer Drugs Products Offered
12.5.5 Sanofi Recent Development
12.6 HANSOH
12.6.1 HANSOH Corporation Information
12.6.2 HANSOH Description and Business Overview
12.6.3 HANSOH Oncology/Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 HANSOH Oncology/Cancer Drugs Products Offered
12.6.5 HANSOH Recent Development
12.7 LUYE
12.7.1 LUYE Corporation Information
12.7.2 LUYE Description and Business Overview
12.7.3 LUYE Oncology/Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 LUYE Oncology/Cancer Drugs Products Offered
12.7.5 LUYE Recent Development
12.8 Novartis
12.8.1 Novartis Corporation Information
12.8.2 Novartis Description and Business Overview
12.8.3 Novartis Oncology/Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Novartis Oncology/Cancer Drugs Products Offered
12.8.5 Novartis Recent Development
12.9 GuiZhou YiBai
12.9.1 GuiZhou YiBai Corporation Information
12.9.2 GuiZhou YiBai Description and Business Overview
12.9.3 GuiZhou YiBai Oncology/Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 GuiZhou YiBai Oncology/Cancer Drugs Products Offered
12.9.5 GuiZhou YiBai Recent Development
12.10 Lunan
12.10.1 Lunan Corporation Information
12.10.2 Lunan Description and Business Overview
12.10.3 Lunan Oncology/Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Lunan Oncology/Cancer Drugs Products Offered
12.10.5 Lunan Recent Development
12.11 Roche
12.11.1 Roche Corporation Information
12.11.2 Roche Description and Business Overview
12.11.3 Roche Oncology/Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Roche Oncology/Cancer Drugs Products Offered
12.11.5 Roche Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Oncology/Cancer Drugs Industry Trends
13.2 Oncology/Cancer Drugs Market Drivers
13.3 Oncology/Cancer Drugs Market Challenges
13.4 Oncology/Cancer Drugs Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Oncology/Cancer Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Oncology/Cancer Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Antimetabolite
Table 3. Major Manufacturers of Alkaloid drugs
Table 4. Major Manufacturers of Hormone
Table 5. Major Manufacturers of Targeted drug
Table 6. Major Manufacturers of Platinum-based drugs
Table 7. Major Manufacturers of Other
Table 8. Global Oncology/Cancer Drugs Market Size Growth Rate by Application (2021-2027) & (K MT)
Table 9. Global Oncology/Cancer Drugs Market Size by Region (K MT) & (US$ Million), 2016 VS 2021 VS 2027
Table 10. Global Oncology/Cancer Drugs Sales by Regions (2016-2021) & (K MT)
Table 11. Global Oncology/Cancer Drugs Sales Market Share by Regions (2016-2021)
Table 12. Global Oncology/Cancer Drugs Revenue by Regions (2016-2021) & (US$ Million)
Table 13. Global Oncology/Cancer Drugs Sales Forecast by Region (2022-2027) & (K MT)
Table 14. Global Oncology/Cancer Drugs Sales Market Share Forecast by Region (2022-2027)
Table 15. Global Oncology/Cancer Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 16. Global Oncology/Cancer Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 17. Global Oncology/Cancer Drugs Sales by Manufacturers (2016-2021) (K MT)
Table 18. Global Oncology/Cancer Drugs Sales Share by Manufacturers (2016-2021)
Table 19. Ranking of Global Top Oncology/Cancer Drugs Manufacturers by Revenue (US$ Million) in 2020
Table 20. Oncology/Cancer Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
Table 21. Oncology/Cancer Drugs Revenue Share by Manufacturers (2016-2021)
Table 22. Global Oncology/Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 23. Global Oncology/Cancer Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology/Cancer Drugs as of 2020)
Table 24. Key Manufacturers Oncology/Cancer Drugs Price (2016-2021) (USD/MT)
Table 25. Oncology/Cancer Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Oncology/Cancer Drugs Product Type
Table 27. Date of International Manufacturers Enter into Oncology/Cancer Drugs Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Oncology/Cancer Drugs Sales by Type (2016-2021) (K MT)
Table 30. Global Oncology/Cancer Drugs Sales Share by Type (2016-2021)
Table 31. Global Oncology/Cancer Drugs Revenue by Type (2016-2021) (US$ Million)
Table 32. Global Oncology/Cancer Drugs Revenue Share by Type (2016-2021)
Table 33. Oncology/Cancer Drugs Average Selling Price (ASP) by Type (2016-2021) & (USD/MT)
Table 34. Global Oncology/Cancer Drugs Sales Forecast by Type (2022-2027) & (K MT)
Table 35. Global Oncology/Cancer Drugs Sales Market Share Forecast by Type (2022-2027)
Table 36. Global Oncology/Cancer Drugs Revenue Forecast V (2022-2027) & (US$ Million)
Table 37. Global Oncology/Cancer Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 38. Global Oncology/Cancer Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/MT)
Table 39. Global Oncology/Cancer Drugs Sales by Application (2016-2021) (K MT)
Table 40. Global Oncology/Cancer Drugs Sales Share by Application (2016-2021)
Table 41. Global Oncology/Cancer Drugs Revenue by Application (2016-2021) (US$ Million)
Table 42. Global Oncology/Cancer Drugs Revenue Share by Application (2016-2021)
Table 43. Oncology/Cancer Drugs Average Selling Price (ASP) by Application (2016-2021) & (USD/MT)
Table 44. Global Oncology/Cancer Drugs Sales Forecast by Application (2022-2027) & (K MT)
Table 45. Global Oncology/Cancer Drugs Sales Market Share Forecast by Application (2022-2027)
Table 46. Global Oncology/Cancer Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 47. Global Oncology/Cancer Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 48. Global Oncology/Cancer Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/MT)
Table 49. United States Oncology/Cancer Drugs Sales (K MT) of Key Companies (2016-2021)
Table 50. United States Oncology/Cancer Drugs Sales Share by Company (2016-2021)
Table 51. United States Oncology/Cancer Drugs Revenue (US$ Million) by Company (2016-2021)
Table 52. United States Oncology/Cancer Drugs Revenue Share by Company (2016-2021)
Table 53. United States Oncology/Cancer Drugs Sales (K MT) by Type (2016-2021)
Table 54. United States Oncology/Cancer Drugs Sales Share by Type (2016-2021)
Table 55. United States Oncology/Cancer Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 56. United States Oncology/Cancer Drugs Price (USD/MT) by Type (2016-2021)
Table 57. United States Oncology/Cancer Drugs Sales (K MT) by Type (2022-2027)
Table 58. United States Oncology/Cancer Drugs Sales Share by Type (2022-2027)
Table 59. United States Oncology/Cancer Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 60. United States Oncology/Cancer Drugs Revenue Share by Type (2022-2027)
Table 61. United States Oncology/Cancer Drugs Price (USD/MT) by Type (2022-2027)
Table 62. United States Oncology/Cancer Drugs Sales (K MT) by Application (2016-2021)
Table 63. United States Oncology/Cancer Drugs Sales Share by Application (2016-2021)
Table 64. United States Oncology/Cancer Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 65. United States Oncology/Cancer Drugs Price (USD/MT) by Application (2016-2021)
Table 66. United States Oncology/Cancer Drugs Sales (K MT) by Application (2022-2027)
Table 67. United States Oncology/Cancer Drugs Sales Share by Application (2022-2027)
Table 68. United States Oncology/Cancer Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 69. United States Oncology/Cancer Drugs Revenue Share by Application (2022-2027)
Table 70. United States Oncology/Cancer Drugs Price (USD/MT) by Application (2022-2027)
Table 71. North America Oncology/Cancer Drugs Sales by Country (2016-2021) & (K MT)
Table 72. North America Oncology/Cancer Drugs Sales Market Share by Country (2016-2021)
Table 73. North America Oncology/Cancer Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 74. North America Oncology/Cancer Drugs Revenue Market Share by Country (2016-2021)
Table 75. Asia Pacific Oncology/Cancer Drugs Sales by Region (2016-2021) & (K MT)
Table 76. Asia Pacific Oncology/Cancer Drugs Sales Market Share by Region (2016-2021)
Table 77. Asia Pacific Oncology/Cancer Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 78. Asia Pacific Oncology/Cancer Drugs Revenue Market Share by Region (2016-2021)
Table 79. Europe Oncology/Cancer Drugs Sales by Country (2016-2021) & (K MT)
Table 80. Europe Oncology/Cancer Drugs Sales Market Share by Country (2016-2021)
Table 81. Europe Oncology/Cancer Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 82. Europe Oncology/Cancer Drugs Revenue Market Share by Country (2016-2021)
Table 83. Latin America Oncology/Cancer Drugs Sales by Country (2016-2021) & (K MT)
Table 84. Latin America Oncology/Cancer Drugs Sales Market Share by Country (2016-2021)
Table 85. Latin Americaa Oncology/Cancer Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 86. Latin America Oncology/Cancer Drugs Revenue Market Share by Country (2016-2021)
Table 87. Middle East and Africa Oncology/Cancer Drugs Sales by Country (2016-2021) & (K MT)
Table 88. Middle East and Africa Oncology/Cancer Drugs Sales Market Share by Country (2016-2021)
Table 89. Middle East and Africa Oncology/Cancer Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 90. Middle East and Africa Oncology/Cancer Drugs Revenue Market Share by Country (2016-2021)
Table 91. Roche Corporation Information
Table 92. Roche Description and Business Overview
Table 93. Roche Oncology/Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 94. Roche Oncology/Cancer Drugs Product
Table 95. Roche Recent Development
Table 96. HENGRUI Corporation Information
Table 97. HENGRUI Description and Business Overview
Table 98. HENGRUI Oncology/Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 99. HENGRUI Product
Table 100. HENGRUI Recent Development
Table 101. AstraZeneca Corporation Information
Table 102. AstraZeneca Description and Business Overview
Table 103. AstraZeneca Oncology/Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 104. AstraZeneca Product
Table 105. AstraZeneca Recent Development
Table 106. QILU Corporation Information
Table 107. QILU Description and Business Overview
Table 108. QILU Oncology/Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 109. QILU Product
Table 110. QILU Recent Development
Table 111. Sanofi Corporation Information
Table 112. Sanofi Description and Business Overview
Table 113. Sanofi Oncology/Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 114. Sanofi Product
Table 115. Sanofi Recent Development
Table 116. HANSOH Corporation Information
Table 117. HANSOH Description and Business Overview
Table 118. HANSOH Oncology/Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 119. HANSOH Product
Table 120. HANSOH Recent Development
Table 121. LUYE Corporation Information
Table 122. LUYE Description and Business Overview
Table 123. LUYE Oncology/Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 124. LUYE Product
Table 125. LUYE Recent Development
Table 126. Novartis Corporation Information
Table 127. Novartis Description and Business Overview
Table 128. Novartis Oncology/Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 129. Novartis Product
Table 130. Novartis Recent Development
Table 131. GuiZhou YiBai Corporation Information
Table 132. GuiZhou YiBai Description and Business Overview
Table 133. GuiZhou YiBai Oncology/Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 134. GuiZhou YiBai Product
Table 135. GuiZhou YiBai Recent Development
Table 136. Lunan Corporation Information
Table 137. Lunan Description and Business Overview
Table 138. Lunan Oncology/Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 139. Lunan Product
Table 140. Lunan Recent Development
Table 141. Eli Lilly and Company Corporation Information
Table 142. Eli Lilly and Company Description and Business Overview
Table 143. Eli Lilly and Company Oncology/Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 144. Eli Lilly and Company Product
Table 145. Eli Lilly and Company Recent Development
Table 146. Oncology/Cancer Drugs Market Trends
Table 147. Oncology/Cancer Drugs Market Drivers
Table 148. Oncology/Cancer Drugs Market Challenges
Table 149. Oncology/Cancer Drugs Market Restraints
Table 150. Oncology/Cancer Drugs Customers List
Table 151. Oncology/Cancer Drugs Distributors List
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Oncology/Cancer Drugs Product Picture
Figure 2. Global Oncology/Cancer Drugs Sales Market Share by Type in 2020 & 2027
Figure 3. Antimetabolite Product Picture
Figure 4. Alkaloid drugs Product Picture
Figure 5. Hormone Product Picture
Figure 6. Targeted drug Product Picture
Figure 7. Platinum-based drugs Product Picture
Figure 8. Other Product Picture
Figure 9. Global Oncology/Cancer Drugs Sales Market Share by Application in 2020 & 2027
Figure 10. Blood Cancer
Figure 11. Breast Cancer
Figure 12. Gastrointestinal Cancer
Figure 13. Prostate Cancer
Figure 14. Respiratory/Lung Cancer
Figure 15. Other
Figure 16. Oncology/Cancer Drugs Report Years Considered
Figure 17. Global Oncology/Cancer Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Oncology/Cancer Drugs Market Size 2016-2027 (US$ Million)
Figure 19. Global Oncology/Cancer Drugs Sales 2016-2027 (K MT)
Figure 20. Global Oncology/Cancer Drugs Market Size Market Share by Region: 2021 Versus 2027
Figure 21. Global Oncology/Cancer Drugs Sales Market Share by Region (2016-2021)
Figure 22. Global Oncology/Cancer Drugs Sales Market Share by Region in 2020
Figure 23. Global Oncology/Cancer Drugs Revenue Market Share by Region (2016-2021)
Figure 24. Global Oncology/Cancer Drugs Revenue Market Share by Region in 2020
Figure 25. Global Oncology/Cancer Drugs Sales Share by Manufacturer in 2020
Figure 26. The Top 10 and 5 Players Market Share by Oncology/Cancer Drugs Revenue in 2020
Figure 27. Oncology/Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Oncology/Cancer Drugs Sales Market Share by Type (2016-2021)
Figure 29. Global Oncology/Cancer Drugs Sales Market Share by Type in 2020
Figure 30. Global Oncology/Cancer Drugs Revenue Market Share by Type (2016-2021)
Figure 31. Global Oncology/Cancer Drugs Revenue Market Share by Type in 2020
Figure 32. Global Oncology/Cancer Drugs Sales Market Share by Application (2016-2021)
Figure 33. Global Oncology/Cancer Drugs Sales Market Share by Application in 2020
Figure 34. Global Oncology/Cancer Drugs Revenue Market Share by Application (2016-2021)
Figure 35. Global Oncology/Cancer Drugs Revenue Market Share by Application in 2020
Figure 36. United States Oncology/Cancer Drugs Sales Growth Rate 2016-2027 (K MT)
Figure 37. United States Oncology/Cancer Drugs Revenue Growth Rate 2016-2027 (US$ Million)
Figure 38. United States Oncology/Cancer Drugs Market Share in Global Market 2016-2027
Figure 39. United States 5 and 10 Largest Oncology/Cancer Drugs Players Market Share by Revenue in Oncology/Cancer Drugs in 2020
Figure 40. United States Oncology/Cancer Drugs Revenue Share by Type (2016-2021)
Figure 41. United States Oncology/Cancer Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 42. United States Oncology/Cancer Drugs Revenue Share by Application (2016-2021)
Figure 43. United States Oncology/Cancer Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 44. North America Oncology/Cancer Drugs Sales Growth Rate 2016-2021 (K MT)
Figure 45. North America Oncology/Cancer Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 46. North America Oncology/Cancer Drugs Sales Market Share by Country in 2020
Figure 47. North America Oncology/Cancer Drugs Revenue Market Share by Country in 2020
Figure 48. U.S. Oncology/Cancer Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 49. U.S. Oncology/Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Canada Oncology/Cancer Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 51. Canada Oncology/Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. Europe Oncology/Cancer Drugs Sales Growth Rate 2016-2021 (K MT)
Figure 53. Europe Oncology/Cancer Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 54. Europe Oncology/Cancer Drugs Sales Market Share by Country in 2020
Figure 55. Europe Oncology/Cancer Drugs Revenue Market Share by Country in 2020
Figure 56. Germany Oncology/Cancer Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 57. Germany Oncology/Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. France Oncology/Cancer Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 59. France Oncology/Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. U.K. Oncology/Cancer Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 61. U.K. Oncology/Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 62. Italy Oncology/Cancer Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 63. Italy Oncology/Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 64. Russia Oncology/Cancer Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 65. Russia Oncology/Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. Asia Pacific Oncology/Cancer Drugs Sales Growth Rate 2016-2021 (K MT)
Figure 67. Asia Pacific Oncology/Cancer Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 68. Asia Pacific Oncology/Cancer Drugs Sales Market Share by Region in 2020
Figure 69. Asia Pacific Oncology/Cancer Drugs Revenue Market Share by Region in 2020
Figure 70. China Oncology/Cancer Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 71. China Oncology/Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Japan Oncology/Cancer Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 73. Japan Oncology/Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. South Korea Oncology/Cancer Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 75. South Korea Oncology/Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. India Oncology/Cancer Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 77. India Oncology/Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Australia Oncology/Cancer Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 79. Australia Oncology/Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Taiwan Oncology/Cancer Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 81. Taiwan Oncology/Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Indonesia Oncology/Cancer Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 83. Indonesia Oncology/Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Thailand Oncology/Cancer Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 85. Thailand Oncology/Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 86. Malaysia Oncology/Cancer Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 87. Malaysia Oncology/Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 88. Philippines Oncology/Cancer Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 89. Philippines Oncology/Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 90. Vietnam Oncology/Cancer Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 91. Vietnam Oncology/Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Latin America Oncology/Cancer Drugs Sales Growth Rate 2016-2021 (K MT)
Figure 93. Latin America Oncology/Cancer Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 94. Latin America Oncology/Cancer Drugs Sales Market Share by Country in 2020
Figure 95. Latin America Oncology/Cancer Drugs Revenue Market Share by Country in 2020
Fig

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global 5-Fluorouracil Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76

The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......

Global Carboplatin Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......

Global Neutropenia Drugs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96

The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......

Global Small Molecule Cancer Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......

Global Capecitabine Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80

Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......

Global Oxaliplatin Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......

Global Cancer Treatment Drugs Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......

Global Capecitabine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93

According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......

Global Methotrexate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs